Summary BAM reported strong Q1 2018 results on May 10, 2018. At the end of Q1 2018 (March 31st), BAM maintained core liquidity and uncalled private fund commitments of $32B. It also generated over $2.5B of annual free cash flow from its asset management business and distributions from invested capital. I wish to have exposure [...]
This is an introduction to my Brookfield Asset Management (BAM) stock analysis which is based on Q1 2018 results. My exposure to BAM allows me to benefit from its expertise and success with alternative asset investments. Summary BAM reported strong Q1 2018 results on May 10, 2018. At the end of Q1 2018 (March 31st), [...]
This is an introduction to my Church & Dwight (CHD) stock analysis which is based on Q1 2018 results and projections for the remainder of FY2018. I view CHD as having better potential to provide superior long-term investor returns than its much larger peer - Procter & Gamble. Summary CHD released its Q1 2018 results [...]
Summary CHD released its Q1 2018 results on May 3rd and upped its projected sales growth and projected organic sales growth guidance from that provided just a few months ago. CHD has outperformed its larger peers in the S&P 500 Household Products Index. I view CHD as having greater potential to provide superior long-term investor [...]
Some investors have gravitated toward High-yield corporate bond ETFs in an effort to generate additional income. There is nothing wrong with investing a component of your portfolio in such an investment on the condition you are fully aware of the risk exposure you are taking on and can withstand a permanent impairment to your capital [...]
This is an introduction to my Procter & Gamble (PG) stock analysis which is based on Q3 2018 results and projections for the remainder of FY2018. PG is a company that generates strong free cash flow and showers investors with dividends and share repurchases. It, however, faces intense competitive pressure and is being pressed by [...]
Summary PG has struggled in recent years with sales having dropped from $82B in 2012 to $65B in 2017. PG has recently signed an agreement to acquire the Consumer Health business of Merck KGaA, for ~$4.1B which will add ~$1B in annual revenue. Strong cash flow has enabled PG to shower investors with dividends and [...]
This is an introduction to my McDonald's (MCD) stock analysis which is based on Q1 2018 results and projections for FY2018. MCD has experienced significant price fluctuation subsequent to the last week of January 2018. I currently view MCD as overvalued. Summary MCD has significantly re-energized its business in the last few years under new [...]
Summary MCD has significantly re-energized its business in the last few years under new leadership. The refranchising strategy has yielded significant cost savings to date. I am bullish on MCD but view it as being currently overvalued at ~$164. I would add to my existing position if it retraces to ~$144. Introduction McDonald’s (NYSE: MCD) [...]
